VPC
ZYME icon

Vestal Point Capital’s Zymeworks ZYME Stock Holding History

Vestal Point Capital’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-865,000
Closed -$22.8M – 111
2025
Q4 		$22.8M Sell
865,000
-900,000
-51% -$19.6M 0.77% 36
2025
Q3 		$30.1M Buy
1,765,000
+615,000
+53% +$8.8M 1.36% 30
2025
Q2 		$14.4M Buy
1,150,000
+650,000
+130% +$7.74M 0.76% 40
2025
Q1 		$5.96M Buy
500,000
+315,000
+170% +$4.3M 0.43% 42
2024
Q4 		$2.71M Sell
185,000
-430,000
-70% -$6.01M 0.16% 64
2024
Q3 		$7.72M Buy
615,000
+175,000
+40% +$1.91M 0.59% 39
2024
Q2 		$3.74M Buy
+440,000
New +$3.92M 0.28% 47

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vestal Point Capital's ZYME Position: Q1 2026 in Review

Vestal Point Capital sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 865,000 shares — an estimated $22.8M sold.

Vestal Point Capital first reported a position in ZYME in Q2 2024 and held it in 7 quarters. The position peaked at $30.1M in Q3 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Vestal Point Capital reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
  • Vestal Point Capital sold 865,000 Zymeworks shares in Q1 2026, an estimated $22.8M.
  • Vestal Point Capital first reported a position in Zymeworks in Q2 2024 and held it in 7 quarters.
  • Vestal Point Capital's Zymeworks position peaked at $30.1M in Q3 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Vestal Point Capital's 13F filing for Q1 2026, filed 15 May 2026.